PAREXEL International Corporation Company Profile (NASDAQ:PRXL)

About PAREXEL International Corporation

PAREXEL International Corporation logoPAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: PRXL
  • CUSIP: 69946210
Key Metrics:
  • Previous Close: $65.94
  • 50 Day Moving Average: $67.68
  • 200 Day Moving Average: $65.68
  • 52-Week Range: $50,954,000.00 - $51.16
  • Trailing P/E Ratio: 23.40
  • Foreward P/E Ratio: 17.13
  • P/E Growth: 1.48
  • Market Cap: $3.36B
  • Outstanding Shares: 50,954,000
  • Beta: 0.82
Profitability:
  • Net Margins: 6.34%
  • Return on Equity: 29.92%
  • Return on Assets: 8.70%
Debt:
  • Debt-to-Equity Ratio: 1.41%
  • Current Ratio: 1.59%
  • Quick Ratio: 1.59%
Additional Links:
Companies Related to PAREXEL International Corporation:

Analyst Ratings

Consensus Ratings for PAREXEL International Corporation (NASDAQ:PRXL) (?)
Ratings Breakdown: 4 Sell Ratings, 10 Hold Ratings
Consensus Rating:Hold (Score: 1.71)
Consensus Price Target: $63.83 (3.19% downside)

Analysts' Ratings History for PAREXEL International Corporation (NASDAQ:PRXL)
Show:
DateFirmActionRatingPrice TargetDetails
2/6/2017Credit Suisse GroupDowngradeOutperform -> NeutralView Rating Details
2/3/2017Deutsche Bank AGDowngradeHold -> Sell$66.00 -> $53.00View Rating Details
2/3/2017Citigroup Inc.DowngradeBuy -> NeutralView Rating Details
2/2/2017Raymond James Financial, Inc.DowngradeMarket Perform -> UnderperformView Rating Details
1/24/2017Jefferies Group LLCBoost Price TargetHold$64.00 -> $67.00View Rating Details
1/4/2017Evercore ISIDowngradeBuy -> Hold$71.50View Rating Details
12/16/2016Goldman Sachs Group, Inc. (The)DowngradeNeutral -> SellView Rating Details
11/23/2016Wells Fargo & CoDowngradeOutperform -> Market PerformView Rating Details
11/17/2016First AnalysisDowngradeOverweight -> Equal Weight$62.00View Rating Details
11/11/2016SunTrust Banks, Inc.DowngradeBuy -> Hold$80.00 -> $60.00View Rating Details
10/27/2016Robert W. BairdDowngradeOutperform -> Neutral$78.00 -> $67.00View Rating Details
7/18/2016William BlairDowngradeOutperform -> Market PerformView Rating Details
5/22/2016KeyCorpReiterated RatingHoldView Rating Details
4/11/2016Avondale PartnersLower Price TargetUnderperform$50.50 -> $49.00View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for PAREXEL International Corporation (NASDAQ:PRXL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2017        
10/26/2016Q117$0.86$0.76$525.15 million$500.90 millionViewListenView Earnings Details
8/3/2016Q416$0.93$0.94$532.41 million$538.60 millionViewListenView Earnings Details
4/27/2016Q316$0.90$0.89$523.16 million$527.10 millionViewListenView Earnings Details
1/27/2016Q2$0.72$0.90$523.03 million$518.50 millionViewListenView Earnings Details
10/28/2015Q116$0.63$0.70$511.77 million$512.10 millionViewListenView Earnings Details
8/5/2015Q415$0.74$0.79$527.13 million$523.00 millionViewListenView Earnings Details
4/29/2015Q315$0.66$0.66$513.50 million$502.03 millionViewListenView Earnings Details
1/28/2015Q215$0.60$0.69$502.20 million$499.27 millionViewListenView Earnings Details
10/30/2014Q115$0.58$0.65$505.60 million$491.69 millionViewListenView Earnings Details
8/7/2014Q414$0.62$0.65$508.99 million$510.60 millionViewListenView Earnings Details
4/29/2014Q314$0.54$0.56$493.35 million$492.40 millionViewListenView Earnings Details
1/30/2014Q214$0.49$0.49$479.49 million$487.10 millionViewListenView Earnings Details
10/30/2013Q114$0.45$0.45$458.94 million$449.20 millionViewListenView Earnings Details
8/7/2013Q4 2013$0.43$0.50$455.23 million$463.10 millionViewListenView Earnings Details
4/30/2013Q3 2013$0.40$0.50$438.10 million$454.49 millionViewListenView Earnings Details
1/29/2013Q2 2013$0.33$0.41$419.78 million$422.10 millionViewListenView Earnings Details
10/30/2012Q113$0.29$0.29$396.70 million$394.80 millionViewN/AView Earnings Details
4/30/2012$0.31$0.33ViewN/AView Earnings Details
1/30/2012$0.23$0.23ViewN/AView Earnings Details
10/31/2011$0.15$0.20ViewN/AView Earnings Details
8/9/2011$0.07$0.10ViewN/AView Earnings Details
5/2/2011$0.30$0.27ViewN/AView Earnings Details
1/31/2011$0.28$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PAREXEL International Corporation (NASDAQ:PRXL)
Current Year EPS Consensus Estimate: $3.25 EPS
Next Year EPS Consensus Estimate: $3.85 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.88$0.91$0.89
Q2 20166$0.96$1.07$1.02
Q3 20164$0.81$1.00$0.92
Q4 20165$0.90$0.94$0.92
Q1 20175$0.85$0.87$0.87
Q2 20175$0.82$0.99$0.89
Q3 20175$0.71$1.08$0.99
Q4 20175$0.91$1.26$1.12
Q1 20181$0.87$0.87$0.87
Q2 20181$0.96$0.96$0.96
(Data provided by Zacks Investment Research)

Dividends

Dividend History for PAREXEL International Corporation (NASDAQ:PRXL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for PAREXEL International Corporation (NASDAQ:PRXL)
Insider Ownership Percentage: 2.90%
Institutional Ownership Percentage: 91.44%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/9/2017Gadi SaaronyInsiderSell2,325$64.54$150,055.50View SEC Filing  
8/15/2016Gadi SaaronyInsiderSell2,500$70.05$175,125.00View SEC Filing  
8/9/2016Joshua SchultzSVPSell2,500$68.64$171,600.00View SEC Filing  
6/13/2016A Dana Callow JrDirectorSell3,000$60.04$180,120.00View SEC Filing  
6/2/2016Eduard E HoldenerDirectorSell700$62.98$44,086.00View SEC Filing  
5/25/2016Ulf I SchneiderSVPSell7,500$62.00$465,000.00View SEC Filing  
5/24/2016Ulf I SchneiderSVPSell6,000$61.00$366,000.00View SEC Filing  
5/23/2016Ulf I SchneiderSVPSell6,000$60.01$360,060.00View SEC Filing  
5/20/2016Ulf I SchneiderSVPSell8,000$59.24$473,920.00View SEC Filing  
3/30/2016Richard L LoveDirectorSell1,330$62.50$83,125.00View SEC Filing  
12/1/2015Richard L LoveDirectorSell1,330$68.21$90,719.30View SEC Filing  
11/24/2015Eduard E HoldenerDirectorSell2,200$67.66$148,852.00View SEC Filing  
11/12/2015Gadi SaaronySVPSell12,425$67.01$832,599.25View SEC Filing  
11/11/2015Patrick J FortuneDirectorSell1,500$68.07$102,105.00View SEC Filing  
9/1/2015Richard L LoveDirectorSell1,330$64.26$85,465.80View SEC Filing  
8/18/2015Mark A GoldbergCOOSell8,995$73.49$661,042.55View SEC Filing  
8/18/2015Thomas SenderovitzSVPSell1,500$74.02$111,030.00View SEC Filing  
6/18/2015Mark A GoldbergCOOSell11,507$70.03$805,835.21View SEC Filing  
5/14/2015Richard L LoveDirectorSell5,000$65.00$325,000.00View SEC Filing  
3/19/2015Mark A GoldbergCOOSell12,884$68.99$888,867.16View SEC Filing  
3/2/2015A Dana Callow JrDirectorSell2,000$65.84$131,680.00View SEC Filing  
2/19/2015Christopher J LindopDirectorSell2,000$63.59$127,180.00View SEC Filing  
2/13/2015Rickenbach Josef H VonCEOSell65,100$62.53$4,070,703.00View SEC Filing  
2/6/2015Eduard E HoldenerDirectorSell3,000$62.97$188,910.00View SEC Filing  
2/4/2015Douglas A BattSVPSell8,300$60.89$505,387.00View SEC Filing  
2/3/2015Gadi SaaronyVPSell8,525$60.97$519,769.25View SEC Filing  
12/3/2014Mark A GoldbergCOOSell25,345$58.99$1,495,101.55View SEC Filing  
11/5/2014Christopher J LindopDirectorSell12,000$55.00$660,000.00View SEC Filing  
8/20/2014Gadi SaaronyVPSell6,075$57.78$351,013.50View SEC Filing  
8/18/2014Anita CooperVPSell4,916$57.56$282,964.96View SEC Filing  
8/15/2014Anita CooperVPSell5,084$57.50$292,330.00View SEC Filing  
8/14/2014Anita CooperVPSell6,800$57.54$391,272.00View SEC Filing  
8/13/2014Mark A GoldbergCOOSell16,761$56.33$944,147.13View SEC Filing  
8/11/2014Richard L LoveDirectorSell6,000$57.33$343,980.00View SEC Filing  
6/5/2014Patrick J FortuneDirectorSell3,000$53.04$159,120.00View SEC Filing  
2/20/2014Anita CooperVPSell2,500$53.00$132,500.00View SEC Filing  
2/18/2014Mark GoldbergCOOSell11,206$52.49$588,202.94View SEC Filing  
2/12/2014Mark GoldbergCOOSell12,199$50.49$615,927.51View SEC Filing  
2/11/2014Anita CooperVPSell10,000$50.00$500,000.00View SEC Filing  
2/10/2014Eduard HoldenerDirectorSell6,000$49.62$297,720.00View SEC Filing  
2/10/2014Rickenbach Josef VonCEOSell50,000$49.76$2,488,000.00View SEC Filing  
2/7/2014Gadi SaaronyVPSell9,950$49.56$493,122.00View SEC Filing  
2/7/2014Rickenbach Josef VonCEOSell50,000$49.70$2,485,000.00View SEC Filing  
2/4/2014Christopher LindopDirectorSell10,000$49.00$490,000.00View SEC Filing  
2/3/2014Douglas BattSVPSell8,000$48.58$388,640.00View SEC Filing  
2/3/2014Mark GoldbergCOOSell13,529$48.70$658,862.30View SEC Filing  
1/13/2014Mark GoldbergCOOSell6,957$48.90$340,197.30View SEC Filing  
1/9/2014Mark GoldbergCOOSell6,901$46.49$320,827.49View SEC Filing  
12/12/2013Xavier FlinoisInsiderBuy5,000$41.11$205,550.00View SEC Filing  
9/11/2013Patrick FortuneDirectorSell7,000$48.31$338,170.00View SEC Filing  
8/28/2013Richard LoveDirectorSell5,000$47.04$235,200.00View SEC Filing  
6/4/2013Douglas A BattSVPSell15,000$45.15$677,250.00View SEC Filing  
6/3/2013Mark A GoldbergCOOSell15,000$45.06$675,900.00View SEC Filing  
5/20/2013Richard L LoveDirectorSell8,000$46.65$373,200.00View SEC Filing  
5/14/2013A Dana Callow JrDirectorSell8,000$46.39$371,120.00View SEC Filing  
5/13/2013Mark A GoldbergCOOSell28,887$45.19$1,305,403.53View SEC Filing  
5/10/2013Anita CooperVPSell10,000$44.99$449,900.00View SEC Filing  
5/9/2013Ulf I SchneiderSVPSell20,510$44.54$913,515.40View SEC Filing  
10/4/2012Mark A GoldbergCOOSell5,000$32.00$160,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PAREXEL International Corporation (NASDAQ:PRXL)
DateHeadline
News IconAre Analysts Optimistic About Where PAREXEL International Corporation (NASDAQ:PRXL) is Heading? - Winfield Review (NASDAQ:PRXL)
winfieldreview.com - February 25 at 1:34 AM
News IconParexel International Corp PRXL Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:PRXL)
www.bioportfolio.com - February 24 at 12:29 AM
News IconMarket Spotlight: Focusing on Shares of PAREXEL International Corporation (NASDAQ:PRXL) - Rives Journal (NASDAQ:PRXL)
rivesjournal.com - February 23 at 7:28 PM
biz.yahoo.com logoPAREXEL INTERNATIONAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Finan (NASDAQ:PRXL)
biz.yahoo.com - February 23 at 7:28 PM
News IconFiscal Year Earnings Estimate on PAREXEL International Corporation(PRXL) - Money Flow Index & Trends (NASDAQ:PRXL)
www.moneyflowtrends.com - February 23 at 8:48 AM
News IconEquity Insight: Indicator Review for PAREXEL International Corp (PRXL) - Baxter Review (NASDAQ:PRXL)
baxternewsreview.com - February 23 at 12:30 AM
News IconSmart Money Buying the Price Weakness of PAREXEL International Corporation (PRXL) - Money Flow Index & Trends (NASDAQ:PRXL)
www.moneyflowtrends.com - February 23 at 12:30 AM
realistinvestor.com logoMean Rating Of PAREXEL International Corporation (NASDAQ:PRXL) At $3.29 (NASDAQ:PRXL)
www.realistinvestor.com - February 22 at 7:29 PM
finance.yahoo.com logoPAREXEL International to Participate at Cowen & Co. Health Care Conference and Barclays Global Healthcare Conference (NASDAQ:PRXL)
finance.yahoo.com - February 22 at 7:29 PM
News IconTaking a Look at the Chart for PAREXEL International Corporation (PRXL) - The USA Commerce (NASDAQ:PRXL)
www.theusacommerce.com - February 18 at 8:04 AM
News IconPAREXEL introduces new mobile app to improve clinical trial supply management processes, increase patient safety (NASDAQ:PRXL)
www.news-medical.net - February 16 at 6:58 PM
realistinvestor.com logoPAREXEL International Corporation (NASDAQ:PRXL) Mean Rating At $3.29 (NASDAQ:PRXL)
www.realistinvestor.com - February 16 at 6:58 PM
News IconTraders Secrets on Apollo Global Management, LLC (APO), PAREXEL International Corporation (PRXL) (NASDAQ:PRXL)
hoyentv.com - February 16 at 6:58 PM
News IconPAREXEL International Corporation (PRXL) Receives Consensus Recommendation of "Hold" from Analysts (NASDAQ:PRXL)
www.graffiotech.com - February 16 at 6:58 PM
finance.yahoo.com logoNajarian: heavy call buying in one health care name (NASDAQ:PRXL)
finance.yahoo.com - February 16 at 6:58 PM
finance.yahoo.com logoPAREXEL INTERNATIONAL CORP Financials (NASDAQ:PRXL)
finance.yahoo.com - February 14 at 11:51 PM
bizjournals.com logoParexel looks to cut down on human errors in clinical trials (NASDAQ:PRXL)
www.bizjournals.com - February 14 at 12:41 AM
finance.yahoo.com logoPAREXEL Launches ClinPhone RTSM Mobile App to Improve Supply Management and Increase Patient Safety (NASDAQ:PRXL)
finance.yahoo.com - February 13 at 9:08 AM
News IconLookout for Price Target? Ultragenyx Pharmaceutical Inc. (RARE), PAREXEL International Corporation (PRXL) - StockNewsJournal (NASDAQ:PRXL)
stocknewsjournal.com - February 11 at 7:25 PM
nasdaq.com logoFalling Earnings Estimates Signal Weakness Ahead for PAREXEL (PRXL) - Nasdaq (NASDAQ:PRXL)
www.nasdaq.com - February 11 at 7:25 PM
finance.yahoo.com logoFalling Earnings Estimates Signal Weakness Ahead for PAREXEL (PRXL) (NASDAQ:PRXL)
finance.yahoo.com - February 10 at 9:30 PM
biz.yahoo.com logoPAREXEL INTERNATIONAL CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:PRXL)
us.rd.yahoo.com - February 9 at 10:02 PM
istreetwire.com logoInvestor's Watch List: Penn National Gaming, Inc. (PENN ... - iStreetWire (NASDAQ:PRXL)
istreetwire.com - February 9 at 2:10 AM
News IconTrading Watch: Reviewing the Numbers for PAREXEL International Corporation (NASDAQ:PRXL) - Baldwin Journal (NASDAQ:PRXL)
baldwinjournal.com - February 9 at 2:10 AM
bizjournals.com logoPAREXEL buys Kennesaw’s Medical Affairs Company (NASDAQ:PRXL)
www.bizjournals.com - February 7 at 9:57 PM
finance.yahoo.com logoPAREXEL International to Present at Leerink Partners Healthcare Conference (NASDAQ:PRXL)
finance.yahoo.com - February 7 at 9:57 PM
News IconPAREXEL International Corporation (PRXL) : How Do the Technicals Stack Up? - The USA Commerce (NASDAQ:PRXL)
www.theusacommerce.com - February 7 at 8:43 AM
News IconParexel International Corp PRXL Financial and Strategic SWOT Analysis Review [Updated: 24012017] Prices from USD $125 (NASDAQ:PRXL)
www.bioportfolio.com - February 4 at 7:26 PM
News IconEarnings Forecast Research on PAREXEL International Corporation (PRXL) (NASDAQ:PRXL)
ibusinesslines.com - February 4 at 7:26 PM
News IconPAREXEL International Corporation (PRXL) is Downgraded by Citigroup to " Neutral" (NASDAQ:PRXL)
fairydetox.org - February 3 at 8:13 PM
News IconPAREXEL International Corporation (PRXL) Releases FY17 Earnings Guidance (NASDAQ:PRXL)
cote-ivoire.com - February 3 at 8:13 PM
News IconOne Stock Analysts Are Watching - PAREXEL International Corporation (NASDAQ:PRXL) (NASDAQ:PRXL)
xboxonezone.com - February 3 at 8:13 PM
us.rd.yahoo.com logoPAREXEL downgraded by Citigroup and Deutsche Bank (NASDAQ:PRXL)
us.rd.yahoo.com - February 3 at 8:13 PM
capitalcube.com logoPAREXEL International Corp. :PRXL-US: Earnings Analysis: Q2, 2017 By the Numbers : February 3, 2017 (NASDAQ:PRXL)
www.capitalcube.com - February 3 at 8:13 PM
News IconPAREXEL Q2 Earnings Top Estimates, Revenues Miss; Sees Higher Margin In Q4 (NASDAQ:PRXL)
mundoaguaysaneamiento.net - February 3 at 2:05 AM
finance.yahoo.com logoEdited Transcript of PRXL earnings conference call or presentation 2-Feb-17 3:00pm GMT (NASDAQ:PRXL)
finance.yahoo.com - February 3 at 2:05 AM
businesswire.com logoPAREXEL Announces Definitive Agreement to Acquire The Medical ... - Business Wire (press release) (NASDAQ:PRXL)
www.businesswire.com - February 2 at 9:04 PM
sg.finance.yahoo.com logoParexel beats 2Q profit forecasts (NASDAQ:PRXL)
sg.finance.yahoo.com - February 2 at 9:04 PM
finance.yahoo.com logoPAREXEL downgraded by Raymond James (NASDAQ:PRXL)
finance.yahoo.com - February 2 at 9:04 PM
biz.yahoo.com logoPAREXEL International Corp Earnings Call scheduled for 10:00 am ET today (NASDAQ:PRXL)
biz.yahoo.com - February 2 at 9:04 PM
bizjournals.com logoParexel to make Georgia acquisition on heels of restructuring news (NASDAQ:PRXL)
www.bizjournals.com - February 2 at 9:04 PM
us.rd.yahoo.com logoPAREXEL International Reports Second Quarter Fiscal Year 2017 Results (NASDAQ:PRXL)
us.rd.yahoo.com - February 2 at 3:05 AM
us.rd.yahoo.com logo2:36 am PAREXEL beats by $0.01, reports revs in-line; guides FY17 EPS below consensus, revs below consensus (NASDAQ:PRXL)
us.rd.yahoo.com - February 2 at 3:05 AM
News IconParexel International Corp (PRXL) Holder Mitchell Capital Management Co Boosted Its Position (NASDAQ:PRXL)
randolphguide.com - February 1 at 10:04 PM
biz.yahoo.com logoQ2 2017 PAREXEL International Corp Earnings Release - After Market Close (NASDAQ:PRXL)
biz.yahoo.com - February 1 at 10:04 PM
finance.yahoo.com logoPAREXEL (PRXL): Moving Average Crossover Alert (NASDAQ:PRXL)
finance.yahoo.com - February 1 at 10:04 PM
finance.yahoo.com logoPAREXEL Announces Definitive Agreement to Acquire The Medical Affairs Company (NASDAQ:PRXL)
finance.yahoo.com - February 1 at 10:04 PM
finance.yahoo.com logo7:01 pm PAREXEL to acquire The Medical Affairs Company; Terms of the transaction were not disclosed (NASDAQ:PRXL)
finance.yahoo.com - February 1 at 10:04 PM
tmcnet.com logoPAREXEL Recognized as a 2017 "Training Top 125" by Training Magazine (NASDAQ:PRXL)
www.tmcnet.com - January 31 at 9:08 PM
finance.yahoo.com logoPAREXEL Recognized as a 2017 “Training Top 125” by Training Magazine (NASDAQ:PRXL)
finance.yahoo.com - January 31 at 9:08 PM

Social

What is PAREXEL International Corporation's stock symbol?

PAREXEL International Corporation trades on the NASDAQ under the ticker symbol "PRXL."

Where is PAREXEL International Corporation's stock going? Where will PAREXEL International Corporation's stock price be in 2017?

14 brokers have issued 1-year price targets for PAREXEL International Corporation's shares. Their forecasts range from $49.00 to $80.00. On average, they anticipate PAREXEL International Corporation's stock price to reach $63.83 in the next twelve months.

When will PAREXEL International Corporation announce their earnings?

PAREXEL International Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.

Who owns PAREXEL International Corporation stock?

PAREXEL International Corporation's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock, Inc (10.20%), State Street Corp (3.08%), Aberdeen Asset Management PLC UK (2.02%), Dimensional Fund Advisors LP (1.46%), Congress Asset Management Co. MA (1.49%) and Frontier Capital Management Co. LLC (1.40%). Company insiders that own PAREXEL International Corporation stock include A Dana Callow Jr, Eduard E Holdener, Gadi Saarony, Joshua Schultz, Mark A Goldberg, Patrick J Fortune, Richard L Love, Thomas Senderovitz and Ulf I Schneider.

Who sold PAREXEL International Corporation stock? Who is selling PAREXEL International Corporation stock?

PAREXEL International Corporation's stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, FMR LLC, Franklin Resources Inc., Guggenheim Capital LLC, Royce & Associates LP, Brown Capital Management LLC, State Street Corp and Aberdeen Asset Management PLC UK. Company insiders that have sold PAREXEL International Corporation stock in the last year include A Dana Callow Jr, Eduard E Holdener, Gadi Saarony, Joshua Schultz, Richard L Love and Ulf I Schneider.

Who bought PAREXEL International Corporation stock? Who is buying PAREXEL International Corporation stock?

PAREXEL International Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Congress Asset Management Co. MA, AQR Capital Management LLC, Tudor Investment Corp Et Al, Oxford Asset Management, Russell Investments Group Ltd., William Harris Investors Inc., Menta Capital LLC and Shelton Capital Management.

How do I buy PAREXEL International Corporation stock?

Shares of PAREXEL International Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of PAREXEL International Corporation stock cost?

One share of PAREXEL International Corporation stock can currently be purchased for approximately $65.94.

PAREXEL International Corporation (NASDAQ:PRXL) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)

Earnings History Chart

Earnings by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)

Dividend History Chart

Dividend Payments by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)

Last Updated on 2/27/2017 by MarketBeat.com Staff